Table 2.
Patient | Sex | Age at initiation (y) | Toxicity | % decrease, [cystine]ur* |
---|---|---|---|---|
1 | F | 6.9 | None | 79% |
2 | M | 2.8 | None | 81% |
3 | M | 1.2 | None | 54% |
4 | F | 11.8 | None | 58% |
5 | M | 1.5 | None | 58% |
6 | F | 2 | None | N/A1 |
7 | F | 17 | None | 38% |
8 | M | 12.5 | None | 36% |
9 | M | 4.3 | None | 51% |
10 | M | 7.3 | None | 5% |
11 | M | 12 | None | 34% |
% decrease, [cystine]ur = decrease in urinary cystine concentration between pretreatment specimen and first specimen on maintenance dose
No pre-treatment specimen available in our records.